Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-009855
Filing Date
2020-04-22
Accepted
2020-04-22 17:30:35
Documents
19
Period of Report
2020-04-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea120972-6k_therapixbio.htm 6-K 11683
2 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON APRIL 22, 2020, TITLED THER ea120972ex99-1_therapixbio.htm EX-99.1 7784
3 CORPORATE PRESENTATION OF THERAPIX BIOSCIENCES LTD., DATED APRIL 2020 ea120972ex99-2_therapixbio.htm EX-99.2 17998
4 GRAPHIC ex99-1_001.jpg GRAPHIC 8099
5 GRAPHIC ex99-2_001.jpg GRAPHIC 342329
6 GRAPHIC ex99-2_002.jpg GRAPHIC 635219
7 GRAPHIC ex99-2_003.jpg GRAPHIC 303111
8 GRAPHIC ex99-2_004.jpg GRAPHIC 434639
9 GRAPHIC ex99-2_005.jpg GRAPHIC 278884
10 GRAPHIC ex99-2_006.jpg GRAPHIC 380125
11 GRAPHIC ex99-2_007.jpg GRAPHIC 197626
12 GRAPHIC ex99-2_008.jpg GRAPHIC 420274
13 GRAPHIC ex99-2_009.jpg GRAPHIC 368810
14 GRAPHIC ex99-2_010.jpg GRAPHIC 313670
15 GRAPHIC ex99-2_011.jpg GRAPHIC 361280
16 GRAPHIC ex99-2_012.jpg GRAPHIC 254033
17 GRAPHIC ex99-2_013.jpg GRAPHIC 165415
18 GRAPHIC ex99-2_014.jpg GRAPHIC 594637
19 GRAPHIC ex99-2_015.jpg GRAPHIC 402762
  Complete submission text file 0001213900-20-009855.txt   7557437
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 20808680
SIC: 2834 Pharmaceutical Preparations